US Patent 10774064 Potassium channel modulators
Patent 10774064 was granted and assigned to Cadent Therapeutics on September, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10774064 Potassium channel modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
